Susquehanna International Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$197K Sell
26,500
-64,300
-71% -$677K ﹤0.01% 11729
2025
Q4
$1.07M Sell
90,800
-33,300
-27% -$359K ﹤0.01% 7032
2025
Q3
$958K Buy
124,100
+59,400
+92% +$416K ﹤0.01% 7465
2025
Q2
$473K Buy
64,700
+38,300
+145% +$309K ﹤0.01% 9300
2025
Q1
$251K Buy
26,400
+13,400
+103% +$167K ﹤0.01% 10469
2024
Q4
$214K Sell
13,000
-38,200
-75% -$593K ﹤0.01% 10585
2024
Q3
$755K Sell
51,200
-32,200
-39% -$504K ﹤0.01% 7472
2024
Q2
$1.16M Sell
83,400
-72,700
-47% -$1.03M ﹤0.01% 6245
2024
Q1
$2.45M Sell
156,100
-41,900
-21% -$647K ﹤0.01% 4900
2023
Q4
$3.2M Buy
198,000
+134,900
+214% +$2.21M ﹤0.01% 4457
2023
Q3
$776K Buy
63,100
+46,200
+273% +$687K ﹤0.01% 7211
2023
Q2
$272K Sell
16,900
-8,900
-34% -$147K ﹤0.01% 9641
2023
Q1
$449K Sell
25,800
-15,300
-37% -$218K ﹤0.01% 8827
2022
Q4
$380K Sell
41,100
-24,700
-38% -$230K ﹤0.01% 8527
2022
Q3
$567K Sell
65,800
-30,300
-32% -$301K ﹤0.01% 8156
2022
Q2
$783K Buy
96,100
+78,200
+437% +$747K ﹤0.01% 7131
2022
Q1
$217K Sell
17,900
-7,100
-28% -$149K ﹤0.01% 11042
2021
Q4
$853K Sell
25,000
-47,800
-66% -$1.87M ﹤0.01% 7720
2021
Q3
$3.51M Buy
72,800
+22,300
+44% +$1.03M ﹤0.01% 4618
2021
Q2
$2.28M Sell
50,500
-7,200
-12% -$319K ﹤0.01% 5618
2021
Q1
$2.78M Buy
57,700
+41,100
+248% +$2.14M ﹤0.01% 5134
2020
Q4
$894K Sell
16,600
-16,000
-49% -$723K ﹤0.01% 6969
2020
Q3
$1.2M Buy
32,600
+8,500
+35% +$316K ﹤0.01% 5672
2020
Q2
$747K Sell
24,100
-68,000
-74% -$1.88M ﹤0.01% 6533
2020
Q1
$2.54M Buy
92,100
+46,200
+101% +$1.38M ﹤0.01% 3551
2019
Q4
$1.34M Buy
45,900
+15,900
+53% +$379K ﹤0.01% 4985
2019
Q3
$574K Sell
30,000
-2,200
-7% -$51.6K ﹤0.01% 6984
2019
Q2
$706K Buy
32,200
+2,800
+10% +$61.4K ﹤0.01% 6491
2019
Q1
$602K Buy
+29,400
New +$511K ﹤0.01% 5924
2016
Q4
Sell
-12,900
Closed -$106K 9937
2016
Q3
$106K Buy
12,900
+200
+2% +$1.68K ﹤0.01% 7914
2016
Q2
$102K Sell
12,700
-10,200
-45% -$81.8K ﹤0.01% 8014
2016
Q1
$154K Buy
22,900
+1,300
+6% +$8.55K ﹤0.01% 8189
2015
Q4
$170K Buy
+21,600
New +$158K ﹤0.01% 8549
2014
Q4
Sell
-11,600
Closed -$60K 9942
2014
Q3
$60K Sell
11,600
-1,400
-11% -$7.19K ﹤0.01% 9187
2014
Q2
$43K Buy
13,000
+2,700
+26% +$8.97K ﹤0.01% 9610
2014
Q1
$36K Buy
+10,300
New +$38.6K ﹤0.01% 8745

Other funds holding NEO

Susquehanna International Group's NEO Position: Q1 2026 in Review

Susquehanna International Group increased its NeoGenomics (NEO) stake by 230% in Q1 2026, buying an estimated $348K and bringing the position to 47,452 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #10518.

Susquehanna International Group first reported a position in NEO in Q4 2013 and has held it in 37 quarters since. The position peaked at $5.23M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Susquehanna International Group held 47,452 shares of NeoGenomics worth $352K as of Q1 2026.
  • Susquehanna International Group bought 33,082 NeoGenomics shares in Q1 2026, an estimated $348K.
  • NeoGenomics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10518 holding.
  • Susquehanna International Group first reported a position in NeoGenomics in Q4 2013 and has held it in 37 quarters since.
  • Susquehanna International Group's NeoGenomics position peaked at $5.23M in Q4 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.